127 related articles for article (PubMed ID: 36341170)
1. Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate.
Grünert SC; Schumann A; Spiekerkoetter U
JIMD Rep; 2022 Nov; 63(6):521-523. PubMed ID: 36341170
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre.
Yeo M; Rehsi P; Dorman M; Grunewald S; Baruteau J; Chakrapani A; Footitt E; Prunty H; McSweeney M
JIMD Rep; 2023 Sep; 64(5):317-326. PubMed ID: 37701329
[TBL] [Abstract][Full Text] [Related]
3. Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Nagamani SC; Diaz GA; Rhead W; Berry SA; Le Mons C; Lichter-Konecki U; Bartley J; Feigenbaum A; Schulze A; Longo N; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Vockley J; Kronn D; Zori R; Cederbaum S; Merritt JL; Wong D; Coakley DF; Scharschmidt BF; Dickinson K; Marino M; Lee BH; Mokhtarani M
Mol Genet Metab; 2015; 116(1-2):29-34. PubMed ID: 26296711
[TBL] [Abstract][Full Text] [Related]
4. Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Smith W; Diaz GA; Lichter-Konecki U; Berry SA; Harding CO; McCandless SE; LeMons C; Mauney J; Dickinson K; Coakley DF; Moors T; Mokhtarani M; Scharschmidt BF; Lee B
J Pediatr; 2013 Jun; 162(6):1228-34, 1234.e1. PubMed ID: 23324524
[TBL] [Abstract][Full Text] [Related]
5. Switch from Sodium Phenylbutyrate to Glycerol Phenylbutyrate Improved Metabolic Stability in an Adolescent with Ornithine Transcarbamylase Deficiency.
Laemmle A; Stricker T; Häberle J
JIMD Rep; 2017; 31():11-14. PubMed ID: 27000017
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study of glyceryl phenylbutyrate therapy for Ornithine transcarbamylase deficiency and a literature review].
Zhou D; Shang X; Qiao Y; Cheng Y; Yu Z; Huang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Sep; 40(9):1107-1112. PubMed ID: 37643956
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
8. Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders.
Yeo M; Rehsi P; Dorman M; Grunewald S; Baruteau J; Chakrapani A; Footitt E; Prunty H; McSweeney M
JIMD Rep; 2022 Mar; 63(2):137-145. PubMed ID: 35281661
[TBL] [Abstract][Full Text] [Related]
9. Glycerol phenylbutyrate for the chronic management of urea cycle disorders.
Oishi K; Diaz GA
Expert Rev Endocrinol Metab; 2014 Sep; 9(5):427-434. PubMed ID: 30736206
[TBL] [Abstract][Full Text] [Related]
10. Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Lichter-Konecki U; Diaz GA; Merritt JL; Feigenbaum A; Jomphe C; Marier JF; Beliveau M; Mauney J; Dickinson K; Martinez A; Mokhtarani M; Scharschmidt B; Rhead W
Mol Genet Metab; 2011 Aug; 103(4):323-9. PubMed ID: 21612962
[TBL] [Abstract][Full Text] [Related]
11. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders.
Longo N; Diaz GA; Lichter-Konecki U; Schulze A; Inbar-Feigenberg M; Conway RL; Bannick AA; McCandless SE; Zori R; Hainline B; Ah Mew N; Canavan C; Vescio T; Kok T; Porter MH; Berry SA
Mol Genet Metab; 2021 Jan; 132(1):19-26. PubMed ID: 33388234
[TBL] [Abstract][Full Text] [Related]
12. Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain.
Martín-Hernández E; Quijada-Fraile P; Correcher P; Meavilla S; Sánchez-Pintos P; de Las Heras Montero J; Blasco-Alonso J; Dougherty L; Marquez A; Peña-Quintana L; Cañedo E; García-Jimenez MC; Moreno Lozano PJ; Murray Hurtado M; Camprodon Gómez M; Barrio-Carreras D; de Los Santos M; Del Toro M; Couce ML; Vitoria Miñana I; Morales Conejo M; Bellusci M
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078975
[TBL] [Abstract][Full Text] [Related]
13. A complex case of delayed diagnosis of ornithine transcarbamylase deficiency in an adult patient with multiple comorbidities.
Abbott J; Senzatimore M; Atwal P
Mol Genet Metab Rep; 2022 Dec; 33(Suppl 1):100916. PubMed ID: 36620385
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.
Berry SA; Longo N; Diaz GA; McCandless SE; Smith WE; Harding CO; Zori R; Ficicioglu C; Lichter-Konecki U; Robinson B; Vockley J
Mol Genet Metab; 2017 Nov; 122(3):46-53. PubMed ID: 28916119
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Lee B; Rhead W; Diaz GA; Scharschmidt BF; Mian A; Shchelochkov O; Marier JF; Beliveau M; Mauney J; Dickinson K; Martinez A; Gargosky S; Mokhtarani M; Berry SA
Mol Genet Metab; 2010 Jul; 100(3):221-8. PubMed ID: 20382058
[TBL] [Abstract][Full Text] [Related]
16. Late-onset ornithine transcarbamylase deficiency: a rare cause of recurrent abnormal behavior in adults.
Hidaka M; Higashi E; Uwatoko T; Uwatoko K; Urashima M; Takashima H; Watanabe Y; Kitazono T; Sugimori H
Acute Med Surg; 2020; 7(1):e565. PubMed ID: 32995020
[TBL] [Abstract][Full Text] [Related]
17. Female heterozygotes for the hypomorphic R40H mutation can have ornithine transcarbamylase deficiency and present in early adolescence: a case report and review of the literature.
Pinner JR; Freckmann ML; Kirk EP; Yoshino M
J Med Case Rep; 2010 Nov; 4():361. PubMed ID: 21070677
[TBL] [Abstract][Full Text] [Related]
18. Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
Berry SA; Lichter-Konecki U; Diaz GA; McCandless SE; Rhead W; Smith W; Lemons C; Nagamani SC; Coakley DF; Mokhtarani M; Scharschmidt BF; Lee B
Mol Genet Metab; 2014 May; 112(1):17-24. PubMed ID: 24630270
[TBL] [Abstract][Full Text] [Related]
19. Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate.
Hook D; Diaz GA; Lee B; Bartley J; Longo N; Berquist W; Le Mons C; Rudolph-Angelich I; Porter M; Scharschmidt BF; Mokhtarani M
Mol Genet Metab Rep; 2016 Mar; 6():34-40. PubMed ID: 27014577
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
